Growth inhibitors of entrepreneurial academic spin-offs: The case of finnish biotechnology

International Journal of Innovation and Technology Management

Volumn 1, Issue 4, 2004, Pages 455-475

  Tahvanainen, Antti Jussi ^a  

^a Elinkeinoelaman Tutkimuslaitos   (Finland)

Author keywords

Academic entrepreneurship; biotechnology; small and medium sized enterprises

Indexed keywords

EID: 84899803434     PISSN: 02198770     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219877004000283     Document Type: Article

References (24)

1. Ahola, E. and Kuisma, M. (1998). Biotekniikkasektori Suomessa- Laboratoriosta lupausten lunastajaksi. Teknologiakatsaus 61/98, Teknologian Kehittämiskeskus, Helsinki.
2. Blanchower, D. G. (2004). Self-employment: More may not be better. Working Paper, Department of Economics, Dartmouth College, Hanover, USA.
3. Cohen, W. M., Levin, R. C. and Mowery, D. C. (1987). Firm size and R&D intensity: A re-examination. Journal of Industrial Economics, 35(4): 543-565.
4. Davidsson, P., Low, M. B. and Wright, M. (2001). Editor's Introduction: Low and MacMillan ten years on: Achievements and future directions for entrepreneurship Research. Entrepreneurship: Theory & Practice, 25(4): 5-15.
5. Deeds, D. L. (2001). The role of R&D intensity, technical development and absorptive capacity in creating entrepreneurial wealth in high technology start-ups. Journal of Engineering and Technology Management, 18: 29-47.
6. Fontes, M. (2001). Biotechnology entrepreneurs and technology transfer in an intermediate economy. Technological Forecasting and Social Change, 66: 59-74.
7. Halme, K. (1994). Uudet yritykset biotekniikkasektorilla 1994. Working papers, No 11/94, VTT, Espoo.
8. Halme, K. (1996). Biotekniikka uusien yritysten toimialana. Working papers, No 24/96, VTT, Espoo.
9. Hermans, R. (2003). Lääkealan biotekniikkayritysten rahoitusrakenteet ja liiketoiminnan ominaispiirteet. DOSIS. Farmaseuttinen Aikakauskirja, 3: 133-145.
10. Hermans, R. and Kauranen, I. (2003). Intellectual capital and anticipated future sales in small and medium-sized biotechnology companies. Discussion papers, No. 856, ETLA, Helsinki.
11. Hermans, R. and Luukkonen, T. (2002). Findings of the ETLA survey on Finnish biotechnology firms. Discussion papers, No. 819, ETLA, Helsinki.
12. Hermans, R. and Tahvanainen, A. -J. (2002). Ownership andfinancial structure of biotechnology SMEs. Evidence from Finland. Discussion papers, No. 835, ETLA, Helsinki.
13. Linnosmaa, I., Hermans, R. and Kauhanen, T. (2002). Price-cost margin in the pharmaceutical industry: Empirical evidence from Finland. Discussion papers, No. 818, ETLA, Helsinki.
14. Nilsson, A. S. (2001). Interaction between researchers, firm managers and venture capitalists-The essence of biotechnology business. Centre for Medical Innovations, Karolinska Institutet, Stockholm.
15. Palmberg, C. and Luukkonen, T. (2004). The commercialisation of knowledge: Differences between the Finnish biotechnology and ICT sectors. Discussion papers, forthcoming, ETLA, Helsinki.
16. Pisano, G. P. (1991). The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry. Research Policy, 20: 237-249.
17. Powell, W. W. (1998). Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries. California Management Review, 40(3): 228-240.
18. Shan, W. (1990). An empirical analysis of organizational strategies by entrepreneurial high-technology firms. Strategic Management Journal, 11: 129-139.
19. Shan, W., Walker, G. and Kogut, B. (1994). Interfirm cooperation and start-up innovation in the biotechnology industry. Strategic Management Journal, 15: 387-394.
20. Smith, J. G. and Fleck, V. (1988). Strategies of new biotechnology firms. Long Range Planning, 21(3): 51-58.
21. Tahvanainen, A.-J. (2003). The capital structure of Finnish biotechnology SMEs-An empirical analysis. Discussion papers, No. 864, ETLA, Helsinki.
22. Tulkki, P., Järvensivu, A. and Lyytinen, A. (2001). The emergence of Finnish life sciences industries. Sitra Reports Series 12: 10-79.
23. Wells, N., Coady, B. and Inge, J. (2003). Spinning off, cashing up and branching out: Commercialisation considerations for bioentrepreneurs in Australasia. Journal of Commer- cial Biotechnology, 9(3): 209-218.
24. Zucker, L. G., Darby, M. R. and Brewer, M. (1998). Intellectual human capital and the birth of US biotechnology enterprises. The American Economic Review, 88(1): 290-360.